Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioprofarma Bagó is a specialized pharmaceutical company based in Argentina and a key subsidiary of the Bagó Group, focusing on high-complexity therapeutic areas. The company is a leader in the Latin American market for biosimilars and high-cost medications, providing essential treatments for oncology, hematology, rheumatology, and infectious diseases. Its portfolio includes advanced biological therapies such as monoclonal antibodies and recombinant proteins, as well as specialized small molecule generics. Bioprofarma Bagó manages the commercialization and distribution of life-saving drugs for conditions like cancer, HIV, and autoimmune disorders, leveraging its parent company's extensive regional infrastructure. The company is recognized for its commitment to expanding access to complex therapies through local manufacturing and strategic international partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioprofarma Bagó.